Back to mobile site

Enzo Biochem, Inc. (ENZ) Widens Q4 Loss to 69c/Share

October 15, 2012 4:16 PM EDT
Enzo Biochem, Inc. (NYSE: ENZ) reported Q4 EPS of ($0.69), versus ($0.11) reported last year. Revenue for the quarter came in at $26.4 million, versus $26.8 million reported last year.

For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings